Risks of new onset and recurrence of tumors in inflammatory bowel disease patients receiving anti-TNF agents
10.3760/cma.j.cn101480-20190519-00073
- VernacularTitle:炎症性肠病患者接受抗肿瘤坏死因子制剂治疗的肿瘤新发与复发风险
- Author:
Mengshi CHEN
1
;
Xiaocang CAO
Author Information
1. 福建省立医院消化内科，福州 350000
- Publication Type:Journal Article
- Keywords:
Inflammatory bowel diseases;
Anti-TNF agents;
Tumor;
Risk
- From:
Chinese Journal of Inflammatory Bowel Diseases
2020;04(2):142-145
- CountryChina
- Language:Chinese
-
Abstract:
The risks of tumors in patients with inflammatory bowel disease (IBD) are significantly higher than that in normal people. It is still obscure whether anti-tumor necrosis factor (anti-TNF) agents increase the risks of malignant tumors in these patients and whether the patients with previous history of malignant tumors could use anti-TNF agents. It becomes an important issue for making clinical decisions.
